{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8104545", "DateCompleted": {"Year": "1993", "Month": "11", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0959-4973", "JournalIssue": {"Volume": "4", "Issue": "4", "PubDate": {"Year": "1993", "Month": "Aug"}}, "Title": "Anti-cancer drugs", "ISOAbbreviation": "Anticancer Drugs"}, "ArticleTitle": "Bristol-Myers Squibb involved in developing alternative sources of TAXOL.", "Pagination": {"StartPage": "517", "EndPage": "520", "MedlinePgn": "517-20"}, "PublicationTypeList": ["News"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Anticancer Drugs", "NlmUniqueID": "9100823", "ISSNLinking": "0959-4973"}, "ChemicalList": [{"RegistryNumber": "P88XT4IS4D", "NameOfSubstance": "Paclitaxel"}], "MeshHeadingList": [{"QualifierName": ["methods"], "DescriptorName": "Chemistry, Pharmaceutical"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["biosynthesis", "chemical synthesis"], "DescriptorName": "Paclitaxel"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1993", "Month": "8", "Day": "1"}, {"Year": "1993", "Month": "8", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1993", "Month": "8", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8104545", "10.1097/00001813-199308000-00015"]}}]}